Drug companies know that a pot of gold is up for grabs if they can only develop a break-through weight loss drug.
It looks like Contrave, one such contender, is one step closer to getting approval from the FDA which will open the drug up for sale in the USA.
At the end of a 56 week treatment study 48.2% of participants lost at least 10% of their body weight.
If you haven't heard about Contrave, it is a blend of two well known drugs;
- Wellbutrin - A drug used to treat depression.
- Bupropion - A drug used to treat alcoholism and addiction.
What's more impressive is that 23% lost at least 15% of their body weight and 61.8% lost at least 5%. Only 23.1% lost 5% of their body weight on the placebo. Not only did the trial show impressive results concerning weight loss, but it also showed improvement in the participants' cholesterol and blood sugar levels.
Contrave is supposed to work differently than other weight loss drugs because it is believed to focus on the central nervous system to inhibit appetite, increase metabolism, reduce cravings, and to off set the body's natural defense of slowing down weight loss in order to preserve itself.
With such promising results and combining drugs that have been in use for 20 years, Contrave just could be the next big thing in weight loss. I guess time will tell if Contrave delivers that miracle or falls short in helping people conquer obesity.